Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
Revenue	$ 5,953	$ 3,792
Operating Expenses
Direct costs	4,290	6,274
Research and development	18,873	11,648
Selling, general and administrative	8,571	7,188
Total operating expenses	31,734	25,110
Operating Loss	(25,781)	(21,318)
Nonoperating Income and Expense
Interest income	5,117	4,835
Change in fair value of warrant liabilities	(501)	(2,662)
Interest expense	(42)	(13)
Total nonoperating income and expense	4,574	2,160
Net Loss Attributable to Common Stockholders	(21,207)	(19,158)
Other Comprehensive Income (Loss)	(579)	885
Comprehensive Loss Attributable to Common Stockholders	$ (21,786)	$ (18,273)
Basic loss per share	$ (0.12)	$ (0.11)
Diluted loss per share	$ (0.12)	$ (0.11)
Weighted average shares outstanding - Basic	180,784,020	176,934,261
Weighted average shares outstanding - Diluted	180,784,020	176,934,261